[et_pb_section fb_built=”1″ _builder_version=”4.25.0″ _module_preset=”default” background_image=”https:\/\/xtrategicalpharma.com\/wp-content\/uploads\/2024\/05\/Design-sem-nome-3.png” custom_padding=”121px||121px|||” locked=”off” global_colors_info=”{}”][et_pb_row _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.19.2″ _module_preset=”default” global_colors_info=”{}”][et_pb_post_title meta=”off” featured_image=”off” _builder_version=”4.19.2″ _module_preset=”default” title_font=”Poppins||||||||” title_text_align=”center” title_text_color=”#FFFFFF” title_font_size=”49px” title_font_size_tablet=”49px” title_font_size_phone=”28px” title_font_size_last_edited=”on|phone” global_colors_info=”{}”][\/et_pb_post_title][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.16″ custom_padding=”40px||0px|||” global_colors_info=”{}”][et_pb_row use_custom_gutter=”on” make_equal=”on” _builder_version=”4.19.2″ background_size=”initial” background_position=”top_left” background_repeat=”repeat” width=”50%” width_tablet=”50%” width_phone=”90%” width_last_edited=”on|phone” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_post_title title=”off” meta=”off” _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”||50px|||” global_colors_info=”{}”][\/et_pb_post_title][et_pb_text _builder_version=”4.27.0″ text_font=”Roboto|300|||||||” text_text_color=”#416AA4″ text_font_size=”16px” background_size=”initial” background_position=”top_left” background_repeat=”repeat” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n
On April 5, 2024, Decree-Law no. 29\/2024, with effect from July 4, 2024, defining the provisions applicable to economic operators, healthcare institutions that manufacture and use devices in their respective facilities, as well as the rules applicable to use and traceability of devices, the designation and supervision of the activities of notified bodies, surveillance and market surveillance, also including conditions and requirements that the reprocessing and use of reprocessed single-use devices must comply with in the national territory.<\/p>\n
[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"
On April 5, 2024, Decree-Law no. 29\/2024, with effect from July 4, 2024, defining the provisions applicable to economic operators, healthcare institutions that manufacture and use devices in their respective facilities, as well as the rules applicable to use and traceability of devices, the designation and supervision of the activities of notified bodies, surveillance and […]<\/p>\n","protected":false},"author":1,"featured_media":393403,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"\r\n
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!<\/p>\r\n","_et_gb_content_width":"2880","footnotes":""},"categories":[24],"tags":[],"class_list":["post-393605","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-noticias-en"],"yoast_head":"\n